Although the rapidly activating delayed rectifier (I Kr ) and it pore-forming subunit HERG have been thought to be insensitive to cAMP-dependent regulation [2, 3] , recent reports have shown PKA-mediated effects on HERG [4, 5] . Moreover, sequence homology of the carboxyl terminus of HERG with cyclic nucleotide binding proteins suggests that cAMP might regulate I Kr independent of its activation of PKA. Thus, we examined the effects of cAMP on HERG K + channels in a heterologous mammalian expression system. Voltage-activated potassium currents typical of HERG/I Kr were measured in CHO cells expressing cloned HERG under whole-cell patch clamp before and after addition of the membrane-permeable cAMP analog, 8-chlorophenylthio-adenosine 3:5′-cyclic monophosphate (CPT-cAMP). A consistent decrease in K + current amplitude occurred within 3 minutes after introduction of 500 µM CPT-cAMP (Figure 1a,c) . With the current reduction, we observed acceleration in the kinetics of voltagedependent deactivation. Both effects occurred within the first 3 minutes of CPT-cAMP administration and persisted for the duration of the experiments. CPT-cAMP reduced HERG current by about 40% at all potentials (Figure 1b) . Both the fast and slow time constants of deactivation were accelerated with the greatest effects at more positive potentials (Figure 1d ). The relative contribution of the fast time constant was increased at all potentials (Figure 1d,  inset) . When the data were independently normalized to unity before and after cAMP, no significant change in voltage-dependence of activation or inactivation due to cAMP was seen (Figure 1b, insets) . Voltage curves were fitted by a Boltzman function,
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where I is the relative tail current amplitude, V is the test potential, V h is the test potential producing halfmaximal current, and k is the slope factor. Analysis revealed a small depolarizing shift in activation after cAMP addition (V h (baseline) = -5.1 ± 0.18 mV, k = 11.1 V h (cAMP) = -4.0 ± 0.26 mV, k = 11.1). cAMP therefore decreases effective HERG activity through current inhibition and accelerated deactivation kinetics with minimal alteration of voltage-dependent activation.
To assess whether cAMP was acting on HERG through PKA, the specific peptide inhibitor PKI was included in the patch pipette and cells were studied after pre-incubation with membrane-permeable myristolated PKI. PKI abolished the cAMP-mediated changes in deactivation kinetics and prevented nearly all of the cAMPmediated current reduction (Figure 2a ). While cAMP alone caused a modest positive shift in voltage-dependence of activation in HERG (+1.1 mV), in the presence of PKI, cAMP produced a leftward shift in both current-voltage and activation curves of 7.5 ± 0.3 mV negative from baseline (V h (baseline) = -3.1 ± 0.22 mV, k = 10.8 V h (cAMP) = -11.6 ± 0.37 mV, k = 12.0). PKI also prevented the cAMP-dependent acceleration of deactivation previously seen (data not shown). No significant changes in current density or deactivation kinetics were elicited by cGMP (data not shown), confirming the cAMPspecificity of our observed effects.
We identified four potential consensus sequence sites for phosphorylation by PKA, (Ser280, Ser887, Thr892, and Ser1134), all predicted to be at intracellular locations. We mutagenized these amino acids to alanines in various combinations to produce a panel of non-PKA phosphorylatable mutants (Figure 3a) . Immunoprecipitation of HERG via a carboxy-terminal Myc epitope tag revealed that the channel protein could be 32 P-phosphorylated in vivo in a cAMP-dependent fashion (Figure 3b ). HERG protein could also be phosphorylated in vitro with the purified catalytic subunit of PKA and [γ-32 P]ATP (Figure 3c ). In contrast to the wild-type channel protein, HERG∆P1-4, a mutant with all four PKA sites removed, was not 32 P-phosphorylated in a cAMP-dependent manner in vivo or in vitro. The specific PKA-dependent phosphorylation of HERG∆P1-4 was <95% compared with wild-type HERG. In vitro assays of mutants with single PKA sites revealed that all were targets for PKA-dependent phosphorylation ( Figure 3d ). The relative contribution to the total PKAdependent phosphorylation by each was: site 1, 61 ± 4%; sites 2,3, 30 ± 3%; site 4, 6.1 ± 1%.
Whole cell patch clamp recordings from cells expressing the PKA mutants all demonstrated recognizable I Kr -type current, but responses to cAMP were different from those of wild-type HERG. At baseline the voltage-activation curve for HERG∆P1-4 was left-shifted compared to wildtype HERG (V h ∆1-4 = -15.9 ± 0.6 mV, k = 7.8). CPTcAMP shifted the voltage-dependent activation of HERG∆P1-4 further negative (V h = -22.9 ± 0.25 mV, k = 9.2; Figure 2b ). Current amplitude after CPT-cAMP was reduced by 9% compared to 40% seen with wild-type HERG. cAMP effects on deactivation kinetics were nearly abolished in HERG∆P1-4 (data not shown). The cAMPmediated effects in individual site mutants were intermediate, indicating that each of the phosphorylation sites contributes to the PKA-dependent effects (Figure 3c,d ).
HERG channel subunits are thought to exist in heteromultimeric complexes with one or more proteins to form cardiac I Kr [6, 7] . To examine the effects of cAMP on human cardiac I Kr we co-expressed HERG or HERG∆1-4 with either minK or hMiRP1. In cells expressing HERG-minK or HERG-hMiRP1, CPT-cAMP produced a leftward shift in voltage-activation and current amplitude inhibition was reduced (with hMiRP1) or absent (with minK) (Figure 2c for HERG-hMiRP1 were -3.0 ± 0.4 mV to -7.5 ± 0.2 mV, respectively (baseline k = 11.7, cAMP k = 10.2). cAMP also generated a greater hyperpolarizing shift in voltagedependent activation for HERG∆1-4 when co-expressed with either minK (V h = -2.4 ± 0.33 mV at baseline to -21.0 ± 0.33 mV after cAMP) or hMiRP1 (V h = -13.7 ± 0.8 mV at baseline to -27.2 ± 0.3 mV after cAMP). Thus, when HERG is in an heteromeric complex, as in cardiac myocytes, the PKA-independent effects of cAMP on I Kr appear to predominate over the PKA-mediated effects.
To investigate a possible direct cAMP-channel interaction, we performed in vitro binding assays of labeled cyclic Brief Communication 673 Figure 3g ). The calculated specific 3 H-cAMP-binding capacity of HERG suggest a stoichiometry of four molecules per channel (1.3 ± 0.24 moles HERG per mole channel subunit). These results are comparable to published binding and stoichiometry data for cyclic nucleotide-gated channels (CNGC) [8, 9] . Gel analysis showed specific photoaffinity labeling of HERG by 8-azido-[γ-32 P]cAMP that could be competitively blocked with excess unlabeled cAMP (above 100 µM; Figure 3h ). Although no specific binding of cGMP was observed in either assay, excess unlabeled cGMP could partially inhibit cAMP binding (Figure 3g , inset).
Taken together, our results show that stimuli that elevate cAMP exert multiple and complex effects on HERG function though separate signaling pathways (see model, Figure 4 ). PKA directly phosphorylates HERG, producing an inhibition of current at all voltages, accelerated deactivation and a rightward shift in voltage dependence of activation. By shifting the voltage-gated activation to more depolarized potentials, PKA-dependent phosphorylation of HERG renders the channel less likely to open during action-potential voltages. PKA-dependent acceleration of deactivation kinetics would reduce the unique control HERG/I Kr has on the rapid repolarizing phase of the cardiac myocyte action potential. Thus, the PKA-dependent effects combine to decrease effective HERG/I Kr activity. Simultaneously, cAMP directly binds to the HERG protein and shifts the voltage-dependence of activation to depolarized potentials. Although this direct effect counterbalances the PKA-dependent shift in voltage activation, the current inhibition and accelerated deactivation remain unopposed, and the net effect is diminution of HERG current. When HERG is complexed with minK or MiRP, however, the relative contribution of direct cAMP effects on I Kr is accentuated.
Distinct channel mutations are associated with different responses to stress and exercise. During adrenergic stimulation in individuals with LQT1, the main cAMP-responsive repolarizing current, I Ks , is reduced or absent. Our data suggest that, for LQT1, stress-induced cAMP may also reduce the only remaining delayed rectifier current, I Kr , thus further impairing repolarization. Our results correlate well with clinical data and provide a mechanistic link in the pathophysiology of stress-induced arrhythmia in LQTS. If the PKA-dependent pathway could be selectively inhibited while cAMP was still allowed to rise, then adrenergic stimulation might have a beneficial effect on myocyte membrane repolarization. Thus, this demonstration of cAMP's dual pathways of HERG regulation may provide a basis for a more genotype-specific therapy.
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